The global microbiome market to reach $1.64 billion by 2030 at 15.0% CAGR, driven by rising healthcare expenditure.
Read More
Neurogenic detrusor overactivity market to reach $2.63 billion by 2030 at 7.6% cagr, driven by rising incidence of neurological disorders.
Read More
Microbiology technology, equipment and consumables market to reach $13.24 billion by 2030 at 11.3% CAGR, driven by increasing hospital-acquired infection rates.
Read More
Neurodegenerative disorder therapeutics market to reach $34.13 billion by 2030 at 9.6% cagr, driven by increasing investment in research and development.
Read More
Microbial sealant market to reach $4.16 billion by 2030 at 8.1% CAGR, driven by increasing number of surgeries and surging number of sports injuries.
Read More
Neurodegenerative disease market to reach $88.5 billion by 2030 at 9.0% cagr, driven by increase in research and clinical trials.
Read More
Microbial api market to reach $95.49 billion by 2030 at 7.0% CAGR, driven by rising prevalence of chronic conditions.
Read More
Netupitant-palonosetron fdc market to reach $608.99 billion by 2030 at 9.6% cagr, driven by increasing prevalence of cancer.
Read More
Mexiletine hydrochloride market to reach $1.93 billion by 2030 at 8.4% CAGR, driven by increasing number of cardiovascular diseases.
Read More
Nerve growth factor market to reach $1.71 billion by 2030 at 7.6% cagr, driven by increasing prevalence of neurological disorders.
Read More